Newsweek discusses a new online platform launched by Doctors Without Borders/Médecins Sans Frontières (MSF) that allows individuals in the United States to know whether they have investments in Pfizer and GSK through their mutual funds or retirements plans (401k) and, if so, contact those companies to insist they drop the price of lifesaving vaccines. View external media.
Due to the absence of “global” solution to provide the pneumonia vaccine at an affordable price during emergencies, MSF had to pay more than 20 times the lowest global price to vaccinate more than 5000 children against the disease in Greece. Pfizer and GSK, the manufacturers of the vaccine, have refused to reduce the price of the vaccine. View external media.
Pfizer and GlaxoSmithKline refuse to lower the price of their pneumonia vaccines, making it harder to treat refugee children in Greece and in other countries with vulnerable populations. MSF has vaccinated more than 5,000 refugee children across Greece. View external media.